Registered number
10647689
PEARSON THERAPIES LIMITED
Filleted Accounts
31 March 2023
PEARSON THERAPIES LIMITED
Registered number: 10647689
Balance Sheet
as at 31 March 2023
Notes 2023 2022
£ £
Fixed assets
Tangible assets 3 4,099 5,465
Current assets
Debtors 4 9,710 4,600
Cash at bank and in hand 33,054 16,033
42,764 20,633
Creditors: amounts falling due within one year 5 (21,585) (17,181)
Net current assets 21,179 3,452
Net assets 25,278 8,917
Capital and reserves
Called up share capital 1 1
Profit and loss account 25,277 8,916
Shareholder's funds 25,278 8,917
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Julia Pearson
Director
Approved by the board on 3 October 2023
PEARSON THERAPIES LIMITED
Notes to the Accounts
for the year ended 31 March 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery straight line over 3 years
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2022 7,287
At 31 March 2023 7,287
Depreciation
At 1 April 2022 1,822
Charge for the year 1,366
At 31 March 2023 3,188
Net book value
At 31 March 2023 4,099
At 31 March 2022 5,465
4 Debtors 2023 2022
£ £
Trade debtors 5,110 -
Office Deposit 4,600 4,600
9,710 4,600
5 Creditors: amounts falling due within one year 2023 2022
£ £
Trade creditors 1,014 -
Taxation and social security costs 14,768 7,708
Other creditors 5,803 9,473
21,585 17,181
6 Other information
PEARSON THERAPIES LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
Flat 1
Knowle House
The Knowle
Hoddesdon
EN11 8LD
PEARSON THERAPIES LIMITED 10647689 false 2022-04-01 2023-03-31 2023-03-31 VT Final Accounts April 2022 Dr Julia Pearson No description of principal activity 10647689 2021-04-01 2022-03-31 10647689 core:WithinOneYear 2022-03-31 10647689 core:ShareCapital 2022-03-31 10647689 core:RetainedEarningsAccumulatedLosses 2022-03-31 10647689 2022-04-01 2023-03-31 10647689 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10647689 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 10647689 bus:Director40 2022-04-01 2023-03-31 10647689 core:PlantMachinery 2022-04-01 2023-03-31 10647689 countries:England 2022-04-01 2023-03-31 10647689 bus:FRS102 2022-04-01 2023-03-31 10647689 bus:FullAccounts 2022-04-01 2023-03-31 10647689 2023-03-31 10647689 core:WithinOneYear 2023-03-31 10647689 core:ShareCapital 2023-03-31 10647689 core:RetainedEarningsAccumulatedLosses 2023-03-31 10647689 core:PlantMachinery 2023-03-31 10647689 2022-03-31 10647689 core:PlantMachinery 2022-03-31 iso4217:GBP xbrli:pure